However, this method can suppress anti-tumor immunity by reducing peripheral and tumor-infiltrating effector immune subsets, increasing immunosuppressive cell subsets, and restraining PD-1/PD-L1 expression in the TME [25]. The gene discussed is CD274; the disease is neoplasm.